grey-arrows-planes
31 July 2013EuropeMatt Smith and Jonathan Wills

Accelerating and decelerating patent prosecution in Europe and the UK

The time it takes for a family of patent applications to progress through patent offices around the world is enormously variable. For many applicants in the life sciences field, delays in the patent application procedure are useful since they delay grant costs, and leave the scope of claims uncrystallised, creating uncertainty for third parties. However, where there is an identifiable product to be pushed to market, there may be a need to get enforceable protection quickly.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
16 January 2026   A first-of-its-kind project by sister title WIPR aims to highlight the world’s leading in-house intellectual property counsel—and it needs your help.
Europe
15 January 2026   Case between AorticLab and Emboline has implications for UPC playbook in terms of requesting security for costs, and conditional counterclaims.
Europe
13 January 2026   As the drug moves deeper into its post-exclusivity phase, a Nordic decision highlights the value of secondary patents, presumption of validity, and interim relief when a drug's core patents expire.